Novavax, Inc.

NVAX

$8.09

Name : Novavax, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,318,151,936.00

EPSttm : 2.58

Novavax, Inc.

$8.09

4.26%

$0.36

NVAX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

31.33

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

-0.25

EPS Last/This Y

-3.08

EPS This/Next Y

0.03

Price

8.09

Target Price

13.78

Analyst Recom

2.44

Performance Q

18.45

Upside

547.2%

Beta

2.59

Ticker: NVAX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	NVAX	10.1	0.47	0.17	210263
2026-03-03	NVAX	9.51	0.47	0.15	214039
2026-03-04	NVAX	9.89	0.47	0.07	216308
2026-03-05	NVAX	9.95	0.47	0.03	218351
2026-03-06	NVAX	9.97	0.46	0.05	221373
2026-03-09	NVAX	10.55	0.47	0.10	210540
2026-03-10	NVAX	10.69	0.46	0.09	214885
2026-03-11	NVAX	10.79	0.46	0.09	215248
2026-03-12	NVAX	10.31	0.46	0.05	216300
2026-03-13	NVAX	10.3	0.46	0.05	216300
2026-03-17	NVAX	10.64	0.47	0.06	212431
2026-03-18	NVAX	10.02	0.44	0.42	224358
2026-03-19	NVAX	9.74	0.44	0.14	228265
2026-03-20	NVAX	9.61	0.44	0.21	231431
2026-03-23	NVAX	9.74	0.45	0.16	218228
2026-03-24	NVAX	9.27	0.44	0.11	223770
2026-03-25	NVAX	9.34	0.44	0.08	224646
2026-03-26	NVAX	8.97	0.44	0.14	224887
2026-03-27	NVAX	8.46	0.45	0.16	226128
2026-03-30	NVAX	8.09	0.45	0.09	218096
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	NVAX	10.10	-11.1	-	2.15
2026-03-03	NVAX	9.50	-111.6	-	-0.36
2026-03-04	NVAX	9.89	-111.6	-	-0.31
2026-03-05	NVAX	9.99	-111.6	-	-0.31
2026-03-06	NVAX	9.97	-111.6	-	-0.31
2026-03-09	NVAX	10.55	-111.6	-	-0.31
2026-03-10	NVAX	10.70	-111.6	-	-0.36
2026-03-11	NVAX	10.80	-111.6	-	-0.36
2026-03-12	NVAX	10.31	-111.6	-	-0.36
2026-03-13	NVAX	10.24	-111.6	-	-0.36
2026-03-17	NVAX	10.65	-111.6	-	-0.36
2026-03-18	NVAX	10.02	-111.6	-	-0.36
2026-03-19	NVAX	9.75	-111.6	-	-0.36
2026-03-20	NVAX	9.62	-111.6	-	-0.36
2026-03-23	NVAX	9.73	-111.6	-	-0.36
2026-03-24	NVAX	9.27	-111.6	-	-0.36
2026-03-25	NVAX	9.33	-111.6	-	-0.36
2026-03-26	NVAX	8.95	-111.6	-	-0.36
2026-03-27	NVAX	8.46	-111.6	-	-0.36
2026-03-30	NVAX	8.09	-111.6	-	-0.36
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	NVAX	0.00	7.85	32.77
2026-03-03	NVAX	0.00	7.85	32.77
2026-03-04	NVAX	0.00	7.85	32.77
2026-03-05	NVAX	0.00	7.85	32.77
2026-03-06	NVAX	0.00	7.85	32.77
2026-03-09	NVAX	0.00	7.85	32.77
2026-03-10	NVAX	0.00	7.85	32.77
2026-03-11	NVAX	0.00	7.85	32.81
2026-03-12	NVAX	0.00	7.85	32.81
2026-03-13	NVAX	0.00	7.85	32.81
2026-03-17	NVAX	0.00	7.91	32.81
2026-03-18	NVAX	0.00	7.91	32.81
2026-03-19	NVAX	0.00	7.91	32.81
2026-03-20	NVAX	0.00	7.91	32.81
2026-03-23	NVAX	0.00	7.92	32.81
2026-03-24	NVAX	0.00	7.92	32.81
2026-03-25	NVAX	0.00	7.92	31.33
2026-03-26	NVAX	0.00	7.92	31.33
2026-03-27	NVAX	0.00	7.92	31.33
2026-03-30	NVAX	0.00	7.91	31.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.11

Avg. EPS Est. Current Quarter

-0.25

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

Institutional Transactions

7.91

Beta

2.59

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.1

Max Drawdown 5-Year %

-98.6

Target Price

13.78

P/E

3.4

Forward P/E

PEG

P/S

1.17

P/B

P/Free Cash Flow

EPS

2.38

Average EPS Est. Cur. Y

-0.36

EPS Next Y. (Est.)

-0.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

39.19

Relative Volume

0.81

Return on Equity vs Sector %

-372.1

Return on Equity vs Industry %

-355.8

EPS 1 7Days Diff

-0.6

EPS 1 30Days Diff

-0.63

EBIT Estimation

◆ NVAX Healthcare

$8.09

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

19/25

Volume

7/15

Valuation

12/20

TP/AR

1/10

Options

8/10

RSI

Range 1M

0.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

18/25

Growth

13/30

Estimates

3/20

Inst/Vol

8/15

Options

7/10

EPS Yr

-113.8%

EPS NY

7.1%

52W%

42.5%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +70.3% upside

Quality

21/30

Valuation

14/30

Growth

10/25

Stability

8/10

LT Trend

3/5

Upside

+70.3%

Quality

Novavax, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 749

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NVAX

Latest News

—

Caricamento notizie per NVAX…

stock quote shares NVAX – Novavax, Inc. Stock Price stock today

news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NVAX – Novavax, Inc. yahoo finance google finance

stock history NVAX – Novavax, Inc. invest stock market

stock prices NVAX premarket after hours

ticker NVAX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVAX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y